WHO ICTRP trial
Research on the Molecular Mechanism of Fibulin-1 Regulating Tumor-Associated…
ChiCTR2500108402 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500108402 |
|---|---|
| Public title | Research on the Molecular Mechanism of Fibulin-1 Regulating Tumor-Associated Fibroblasts to Promote Ovarian Cancer Metastasis |
| Scientific title | Research on the Molecular Mechanism of Fibulin-1 Regulating Tumor-Associated Fibroblasts to Promote Ovarian Cancer Metastasis |
| Primary sponsor | The First Affiliated Hospital of Ningbo University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Ovarian cancer |
| Interventions | Ovarian cancer group:N/A |
| Registration date | Aug 29, 2025 |
| Target size | Ovarian cancer group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: